Founded
2020
Legal Status
Charitable company
Leader
Dr David Garnett
For the public benefit, the relief of sickness by conducting research into new treatments for various forms of cancers and disseminating the useful results for the public benefit, with a view to making such treatments available to oncology clinicians to treat cancer patients
Year ending 2025
Income & expenditure over time
Europe